This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Alomone Labs
product type :
chemical
product name :
Nimodipine
catalog :
N-150
quantity :
250 mg, 1 g, 5 g, 10 g
citations: 2
Reference
Sieber A, Min R, Nevian T. Non-Hebbian long-term potentiation of inhibitory synapses in the thalamus. J Neurosci. 2013;33:15675-85 pubmed publisher
Lv P, Sihn C, Wang W, Shen H, Kim H, Rocha Sanchez S, et al. Posthearing Ca(2+) currents and their roles in shaping the different modes of firing of spiral ganglion neurons. J Neurosci. 2012;32:16314-30 pubmed publisher
product information
Vendor :
Alomone Labs Ltd.
Item Name :
Nimodipine
Catalog Number :
N-150
Size :
250 mg, 1 g, 5 g, 10 g
Type :
Antagonists Inhibitors
Molecule Name :
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5 pyridinedicarboxylic acid 2-methyloxyethyl 1-methylethyl ester.
CAS Number :
66085-59-4
Source/Expression System :
Synthetic
Activity :
Nimodipine is a dihydropyridine that acts as L-type, voltage-gated Ca2+ channel blocker and is used in the clinic to treat hypertension. Nimodipine inhibits L- type Cav channels with IC50 of about 10 #956M and has little effect on other Cav channels at this concentration.
Molecular Weight :
418.4
Gene symbol :
CACNA1S, CACNA1C, CACNA1D, CACNA1F
Target :
L-type Ca2+ channels
Formula :
C21H26N2O7
Format :
Lyophilized/solid.
Purity :
99%
Product Description :
A Potent Blocker of L-Type Cav Channels
Category :
Ca2+ signaling, Ca2+ signalling, Ion Channels, Chemicals and Reagents, Inhibitors, Biomolecules, Blockers, Antagonists
Research Area :
Cardiovascular, Cardiac, Heart, Alzheimer's Disease, Neurodegenerative Disorders, Neuroscience
company information
Alomone Labs
Jerusalem BioPark (JBP), Hadassah Ein Kerem
P.O. Box 4287
Jerusalem 9104201
info@alomone.com
http://www.alomone.com
972 2 531 8002
headquarters: Israel